OVERWEIGHT OR OBESITY

Clinical trials for OVERWEIGHT OR OBESITY explained in plain language.

Never miss a new study

Get alerted when new OVERWEIGHT OR OBESITY trials appear

Sign up with your email to follow new studies for OVERWEIGHT OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 25 Not yet recruiting 4 Not yet finished but already full! 12 Completed 17 Terminated 1

Fatty liver drug trial halted early: what we learned

Disease control Terminated

This early-stage study tested an experimental drug called FT-4101 in 14 overweight or obese adults with NASH, a serious fatty liver disease. The main goals were to check safety and see if the drug could reduce liver fat. The study was stopped early, so results are limited, but it…

Matched conditions: OVERWEIGHT OR OBESITY

Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control

Last updated May 17, 2026 00:53 UTC

OVERWEIGHT OR OBESITY

Get alerted when new OVERWEIGHT OR OBESITY trials appear

Fatty liver drug trial halted early: what we learned